We are live on ! Find out more
ZOM

Zomedica Corp.
ZOM

Delisted

ZOM was delisted on the 4th of March, 2025.

Back to rankings

110 hedge funds and large institutions have $38.3M invested in Zomedica Corp. in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 22 increasing their positions, 22 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 18

3% more funds holding

Funds holding: 107 → 110 (+3)

1% more capital invested

Capital invested by funds: $37.8M → $38.3M (+$525K)

0% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 22

Holders
110
Holders Change
+3
Holders Change %
+2.8%
% of All Funds
1.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
22
Reduced
22
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$404K
2
BlackRock
BlackRock
New York
+$232K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$136K
4
HF
HRT Financial
New York
+$89.5K
5
SCA
Snowden Capital Advisors
New York
+$58.9K

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$3.28M
2
N
Nuveen
North Carolina
-$349K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$337K
4
UBS AM
UBS AM
Illinois
-$251K
5
CSS
Cubist Systematic Strategies
Connecticut
-$176K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$13.7M -$337K -1,028,539 -2%
State Street
2
State Street
Massachusetts
$6.31M -$3.28M -10,012,508 -35%
BlackRock
3
BlackRock
New York
$4.52M +$232K +707,993 +6%
Cambridge Investment Research Advisors
4
Cambridge Investment Research Advisors
Iowa
$3.76M +$7.69K +23,500 +0.2%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$2.75M +$136K +416,617 +5%
BBHC
6
Brown Brothers Harriman & Co
New York
$770K – – –
Northern Trust
7
Northern Trust
Illinois
$743K -$13.3K -40,530 -2%
Swiss National Bank
8
Swiss National Bank
Switzerland
$742K +$51.1K +156,100 +8%
Citadel Advisors
9
Citadel Advisors
Florida
$617K +$404K +1,234,666 +207%
GCP
10
GSA Capital Partners
United Kingdom
$414K +$10.3K +31,377 +3%
PWMG
11
Pinnacle Wealth Management Group
Michigan
$395K – – –
VF
12
Virtu Financial
New York
$270K -$105K -319,997 -29%
California State Teachers Retirement System (CalSTRS)
13
California State Teachers Retirement System (CalSTRS)
California
$265K – – –
Goldman Sachs
14
Goldman Sachs
New York
$231K -$30.6K -93,487 -12%
UBS AM
15
UBS AM
Illinois
$221K -$251K -766,008 -54%
Morgan Stanley
16
Morgan Stanley
New York
$206K -$6.72K -20,550 -3%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$196K -$119K -363,047 -38%
CS
18
Credit Suisse
Switzerland
$182K +$12.9K +39,290 +8%
Victory Capital Management
19
Victory Capital Management
Texas
$159K +$8.88K +27,130 +4%
Legal & General Group
20
Legal & General Group
United Kingdom
$125K – – –
Charles Schwab
21
Charles Schwab
California
$116K – – –
Zurich Cantonal Bank
22
Zurich Cantonal Bank
Switzerland
$92K +$44.7K +136,491 +100%
HF
23
HRT Financial
New York
$92K +$89.5K +273,588 New
ASRS
24
Arizona State Retirement System
Arizona
$85K +$370 +1,131 +0.5%
Commonwealth Equity Services
25
Commonwealth Equity Services
Massachusetts
$74K -$1.66K -5,086 -2%
1
2 3 4 5

ZOM Hedge Fund Activity: Q1 2022 in Review

110 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q1 2022, worth a combined $38.3M — up 1.4% from $37.8M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new ZOM positions and 18 closed out — a net gain of 4 holders — while 22 added to existing stakes and 22 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $404K. The largest seller was State Street, cutting an estimated $3.28M.

  • 110 institutional investors held Zomedica Corp. (ZOM) as of Q1 2022, up from 107 in Q4 2021.
  • Funds reported $38.3M of Zomedica Corp. stock for Q1 2022, up 1.4% quarter-over-quarter.
  • 22 funds opened new Zomedica Corp. positions in Q1 2022 and 18 closed out, a net change of +4 holders.
  • The largest Zomedica Corp. buyer in Q1 2022 was Citadel Advisors, an estimated $404K added.
  • The largest Zomedica Corp. seller in Q1 2022 was State Street, an estimated $3.28M sold.

Based on aggregated 13F filings for Q1 2022.